286 related articles for article (PubMed ID: 27765793)
1. A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome.
Limpitikul WB; Dick IE; Tester DJ; Boczek NJ; Limphong P; Yang W; Choi MH; Babich J; DiSilvestre D; Kanter RJ; Tomaselli GF; Ackerman MJ; Yue DT
Circ Res; 2017 Jan; 120(1):39-48. PubMed ID: 27765793
[TBL] [Abstract][Full Text] [Related]
2. Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome-Associated Calmodulin Missense Variant, E141G.
Boczek NJ; Gomez-Hurtado N; Ye D; Calvert ML; Tester DJ; Kryshtal D; Hwang HS; Johnson CN; Chazin WJ; Loporcaro CG; Shah M; Papez AL; Lau YR; Kanter R; Knollmann BC; Ackerman MJ
Circ Cardiovasc Genet; 2016 Apr; 9(2):136-146. PubMed ID: 26969752
[TBL] [Abstract][Full Text] [Related]
3. Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation.
Yamamoto Y; Makiyama T; Harita T; Sasaki K; Wuriyanghai Y; Hayano M; Nishiuchi S; Kohjitani H; Hirose S; Chen J; Yokoi F; Ishikawa T; Ohno S; Chonabayashi K; Motomura H; Yoshida Y; Horie M; Makita N; Kimura T
Hum Mol Genet; 2017 May; 26(9):1670-1677. PubMed ID: 28335032
[TBL] [Abstract][Full Text] [Related]
4. Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes.
Pipilas DC; Johnson CN; Webster G; Schlaepfer J; Fellmann F; Sekarski N; Wren LM; Ogorodnik KV; Chazin DM; Chazin WJ; Crotti L; Bhuiyan ZA; George AL
Heart Rhythm; 2016 Oct; 13(10):2012-9. PubMed ID: 27374306
[TBL] [Abstract][Full Text] [Related]
5. Novel
Kato K; Isbell HM; Fressart V; Denjoy I; Debbiche A; Itoh H; Poinsot J; George AL; Coulombe A; Shea MA; Guicheney P
Circ Arrhythm Electrophysiol; 2022 Mar; 15(3):e010572. PubMed ID: 35225649
[TBL] [Abstract][Full Text] [Related]
6. Genetic Mosaicism in Calmodulinopathy.
Wren LM; Jiménez-Jáimez J; Al-Ghamdi S; Al-Aama JY; Bdeir A; Al-Hassnan ZN; Kuan JL; Foo RY; Potet F; Johnson CN; Aziz MC; Carvill GL; Kaski JP; Crotti L; Perin F; Monserrat L; Burridge PW; Schwartz PJ; Chazin WJ; Bhuiyan ZA; George AL
Circ Genom Precis Med; 2019 Sep; 12(9):375-385. PubMed ID: 31454269
[TBL] [Abstract][Full Text] [Related]
7. Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks.
Gomez-Hurtado N; Boczek NJ; Kryshtal DO; Johnson CN; Sun J; Nitu FR; Cornea RL; Chazin WJ; Calvert ML; Tester DJ; Ackerman MJ; Knollmann BC
Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27516456
[TBL] [Abstract][Full Text] [Related]
8. Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Rocchetti M; Sala L; Dreizehnter L; Crotti L; Sinnecker D; Mura M; Pane LS; Altomare C; Torre E; Mostacciuolo G; Severi S; Porta A; De Ferrari GM; George AL; Schwartz PJ; Gnecchi M; Moretti A; Zaza A
Cardiovasc Res; 2017 Apr; 113(5):531-541. PubMed ID: 28158429
[TBL] [Abstract][Full Text] [Related]
9. Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies.
Wu JC; Garg P; Yoshida Y; Yamanaka S; Gepstein L; Hulot JS; Knollmann BC; Schwartz PJ
Circ Res; 2019 Aug; 125(6):653-658. PubMed ID: 31465267
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.
Limpitikul WB; Dick IE; Joshi-Mukherjee R; Overgaard MT; George AL; Yue DT
J Mol Cell Cardiol; 2014 Sep; 74():115-24. PubMed ID: 24816216
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms.
Yin G; Hassan F; Haroun AR; Murphy LL; Crotti L; Schwartz PJ; George AL; Satin J
J Am Heart Assoc; 2014 Jun; 3(3):e000996. PubMed ID: 24958779
[TBL] [Abstract][Full Text] [Related]
12. Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry.
Crotti L; Spazzolini C; Tester DJ; Ghidoni A; Baruteau AE; Beckmann BM; Behr ER; Bennett JS; Bezzina CR; Bhuiyan ZA; Celiker A; Cerrone M; Dagradi F; De Ferrari GM; Etheridge SP; Fatah M; Garcia-Pavia P; Al-Ghamdi S; Hamilton RM; Al-Hassnan ZN; Horie M; Jimenez-Jaimez J; Kanter RJ; Kaski JP; Kotta MC; Lahrouchi N; Makita N; Norrish G; Odland HH; Ohno S; Papagiannis J; Parati G; Sekarski N; Tveten K; Vatta M; Webster G; Wilde AAM; Wojciak J; George AL; Ackerman MJ; Schwartz PJ
Eur Heart J; 2019 Sep; 40(35):2964-2975. PubMed ID: 31170290
[TBL] [Abstract][Full Text] [Related]
13. Calmodulin Mutations in Human Disease.
Hussey JW; Limpitikul WB; Dick IE
Channels (Austin); 2023 Dec; 17(1):2165278. PubMed ID: 36629534
[TBL] [Abstract][Full Text] [Related]
14. Long QT syndrome-associated calmodulin variants disrupt the activity of the slowly activating delayed rectifier potassium channel.
McCormick L; Wadmore K; Milburn A; Gupta N; Morris R; Held M; Prakash O; Carr J; Barrett-Jolley R; Dart C; Helassa N
J Physiol; 2023 Sep; 601(17):3739-3764. PubMed ID: 37428651
[TBL] [Abstract][Full Text] [Related]
15. Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.
Chavali NV; Kryshtal DO; Parikh SS; Wang L; Glazer AM; Blackwell DJ; Kroncke BM; Shoemaker MB; Knollmann BC
Heart Rhythm; 2019 Nov; 16(11):1686-1695. PubMed ID: 31004778
[TBL] [Abstract][Full Text] [Related]
16. Calmodulin variant E140G associated with long QT syndrome impairs CaMKIIδ autophosphorylation and L-type calcium channel inactivation.
Prakash O; Gupta N; Milburn A; McCormick L; Deugi V; Fisch P; Wyles J; Thomas NL; Antonyuk S; Dart C; Helassa N
J Biol Chem; 2023 Jan; 299(1):102777. PubMed ID: 36496072
[TBL] [Abstract][Full Text] [Related]
17. Calmodulinopathy in Japanese Children - Their Cardiac Phenotypes Are Severe and Show Early Onset in Fetal Life and Infancy.
Fukuyama M; Horie M; Kato K; Aoki H; Fujita S; Yoshida Y; Sakazaki H; Toda T; Ueno M; Izumi G; Momoi N; Muneuchi J; Makiyama T; Nakagawa Y; Ohno S
Circ J; 2023 Nov; 87(12):1828-1835. PubMed ID: 37380439
[TBL] [Abstract][Full Text] [Related]
18. Modelling the long QT syndrome with induced pluripotent stem cells.
Itzhaki I; Maizels L; Huber I; Zwi-Dantsis L; Caspi O; Winterstern A; Feldman O; Gepstein A; Arbel G; Hammerman H; Boulos M; Gepstein L
Nature; 2011 Mar; 471(7337):225-9. PubMed ID: 21240260
[TBL] [Abstract][Full Text] [Related]
19. A bilobal model of Ca
Limpitikul WB; Greenstein JL; Yue DT; Dick IE; Winslow RL
J Gen Physiol; 2018 Dec; 150(12):1688-1701. PubMed ID: 30470716
[TBL] [Abstract][Full Text] [Related]
20. Precision medicine for long QT syndrome: patient-specific iPSCs take the lead.
Yu Y; Deschenes I; Zhao MT
Expert Rev Mol Med; 2023 Jan; 25():e5. PubMed ID: 36597672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
